Nutrition and ulcerative colitis

Bailliere's Clinical Gastroenterology

Volumn 11, Issue 1, 1997, Pages 153-174

  Burke, Ann ^a   Lichtenstein, Gary R ^a   Rombeau, John L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anti oxidants; Butyrate; Fish oil; Ulcerative colitis

Indexed keywords

ANTIOXIDANT; BUTYRIC ACID; CALCIUM; ENEMA; FISH OIL; FOLIC ACID; GAMMA LINOLENIC ACID; GLUCOCORTICOID; ICOSAPENTAENOIC ACID; MESALAZINE; PANTOTHENIC ACID; SULFIDE; TRACE ELEMENT; VITAMIN D;

ADJUVANT THERAPY; BACTERIUM; CARBOHYDRATE DIET; COLORECTAL CARCINOMA; DIET; DIET SUPPLEMENTATION; DIET THERAPY; FERMENTATION; HUMAN; MALNUTRITION; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SWINE; TISSUE INJURY; TOTAL PARENTERAL NUTRITION; TOXIC MEGACOLON; ULCERATIVE COLITIS;

EID: 0030962964     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(97)90059-2     Document Type: Article

References (118)

1. Adler RA & Rosen CJ (1994) Glucocorticoids and osteoporosis. Endocrinology and Metabolism Clinics of North America 23: 641-654.
2. Afonso JJ & Rombeau JL (1990) Parenteral nutrition for patients with inflammatory bowel disease. In Rombeau JL (ed.) Clinical Nutrition: Parenteral Nutrition, pp 427-441. Philadelphia: W.B. Saunders.
3. Ahnfelt-Ronne I, Nielsen OH, Christensen A et al (1990) Clinical evidence supporting the radical scavenging mechanism of 5-aminosalicyclic acid. Gastroenterology 98: 1162-1169.
4. Ainley CC, Cason J, Carlsson LK et al (1988) Zinc status in inflammatory bowel disease. Clinical Science 75: 277-283.
5. Alberts, DS, Hixson L, Ahnen D et al (1995) Do NSAIDs exert their colon cancer chemoprotective activities through the inhibition of mucosal prostaglandin synthetase? Journal of Cellular Biochemistry supplement 22: 18-23.
6. Asian A & Triadafilopoulos G (1992) Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled cross-over study. American Journal of Gastroenterology 87: 432-437.
7. ASPEN Board of Directors (1986) Guidelines for the use of total parenteral nutrition in the hospitalised adult patient. Journal of Parenteral and Enteral Nutrition 10: 441-445.
8. Babbs CF (1992) Oxygen radicals in ulcerative colitis. Free Radical Biology and Medicine 13: 169-181.
9. Baker JP, Detsky AS, Wesson DE et al (1982) Nutritional assessment. A comparison of clinical judgement and objective measurements. New England Journal of Medicine 306: 969-972.
10. Bartels M, Nagel E & Pichlmayr R (1995) Welche Rolle spielt die Ernaehrung bie der Colitis Ulcerosa? Ein Beitrag zum heutigen Stellenwert der diaetetischen Therapie in der Behandlung entzuendlicher Darmerkrankungen. Langenbecks Archiv der Chirurgie 380: 4-11.
11. Bennet JD (1986) Use of α-tocopherylquinone in the treatment of ulcerative colitis. Personal experience. Gut 27: 695-697.
12. Bhaskar L, Ramakrishna BS & Balasubramanian KA (1995) Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 10: 140-143.
13. Buffington G & Doe WF (1995) Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radical Biology and Medicine 19: 911-918.
14. Burkitt DP (1973) Some diseases characteristic of modern western civilization. British Medical Journal 1: 274-278.
15. Burress Welbom M & Moldawer LL (1997) Glucose metabolism. In Rombeau JL & Rolandelli RH (eds) Clinical Nutrition: Enteral and Tube Feeding, 3rd edn, pp 61-80. Philadelphia: W.B. Saunders.
16. Chapman MAS, Grahn MF, Boyle MA et al (1994) Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescient ulcerative colitis. Gut 35: 73-76.
17. Cummings JH, Pomare EW, Branch WJ et al (1987) Short chain fatty acids in human large intestine, portal hepatic and venous blood. Gut 28: 1221-1227.
18. D'Argenio G, Cosenza V, Delle Cave M et al (1996) Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 110: 1727-1734.
19. Dean RE, Campos MM & Barrett B (1976) Hyperalimentation in the management of chronic inflammatory intestinal disease. Disease of the Colon and Rectum 19: 601-604.
20. DeLuca P, Rothman D & Zurier RB (1995) Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis. Rheumatic Disease Clinics of North America 21: 759-777.
21. Detsky AS, McLaughlin JR, Baker JP et al (1987) What is subjective global assessment of nutritional status? Journal of Parenteral and Enteral Nutrition 11: 8-13.
22. Detsky AS, Smalley PS & Chang J (1994) Is this patient malnourished? JAMA 271: 54-58.
23. Dexter DL, Lev R, McKendall GR et al (1984) Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells. Histochemical Journal 16: 137-149.
24. Dickson RJ, Ashton MG, Axon ATR et al (1980) Controlled trial of intravenous hyperalimentation and total bowel rest: as an adjunct to the routine therapy of acute colitis. Gastroenterology 79: 1199-1204.
25. DuBois RN, Radhika A, Reddy BS et al (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262.
26. Ellestad-Sayed JJ, Nelson RA, Adson MA et al (1976) Pantothenic acid, coenzyme-A and human chronic ulcerative and granulomatous colitis. American Journal of Clinical Nutrition 29: 1333-1338.
27. Eloranta TO (1977) Tissue distribution of 5-adenosylmethionine and S-adenosylhomocysteine in the rat. Biochemical Journal 166: 521-529.
28. Elson CO, Layden TJ, Nemchausky BA et al (1980) An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Digestive Diseases and Sciences 25: 42-48.
29. Fazio VW, Kodner I, Jagelman DG et al (1976) Parenteral nutrition as primary or adjunctive treatment. Diseases of the Colon and Rectum 19: 574-578.
30. Fernandez-Banares F, Abad-Lacruz A. Xiol X et al (1989) Vitamin status in patients with inflammatory bowel disease. American Journal of Gastroenterology 84: 744-748.
31. Fernandez-Banares F, Mingorance MD, Esteve M et al (1990) Serum zinc, copper and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. American Journal of Gastroenterology 85: 1584-1589.
32. Fields JZ, Keshavarzian, A & Einzhamer D (1994) Low levels of blood and colonic glutathione in ulcerative colitis. Gastroenterology 106: A680 (abstract).
33. Fischer JE, Foster GS, Abel RM & et al (1973) Hyperalimentation as primary therapy for inflammatory bowel disease. American Journal of Surgery 125: 165-179.
34. Fleming SE & Arce DS (1986) Volatile fatty acids: their production, absorption, utilization, and roles in human health. Clinics in Gastroenterology 15: 787-814.
35. Florin THJ, Gibson GR, Neale G et al (1990) A role for sulphate reducing bacteria in ulcerative colitis. Gastroenterology 98: A170 (abstract).
36. Florin T, Neale G, Gibson GR et al (1991) Metabolism of dietary sulphate: absorption and excretion in humans. Gut 32: 766-773.
37. 2 formation by activated polymorphonuclear leukocytes. Carcinogenesis 8: 1207-1212.
38. Gassull MA, Fernandez-Banares F & Esteve-Comos M (1995) Nutrition in inflammatory bowel disease. In Payne-James J et al (eds) Artificial Nutrition Support in Clinical Practice, pp 443-458. London: Edward Arnold.
39. Gassull MA, Fernandez-Banares F, Cabre E et al (1996) Enteral nutrition in inflammatory bowel disease. In Rombeau JL & Rolandelli RH (eds) Clinical Nutrition: Enteral and Tube Feeding, 3rd edn, pp 403-416. Philadelphia: W.B. Saunders.
40. Gibson GR, Cummings JH & McFarlane GT (1991) Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiology Ecology 86: 103-112.
41. Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M et al (1993) Enteral vs parenteral nutrition as adjunct therapy in acute ulcerative colitis. American Journal of Gastroenterology 88: 227-232.
42. Greenfield SM, Green AT, Teare JP et al (1993) A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Alimentary Pharmacology and Therapeutics 7: 159-166.
43. Grimminger F, Fuehrer D, Papavassilis C et al (1993) Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis. European Journal of Clinical Investigation 23: 706-715.
44. Grisham MB (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344: 859-861.
45. Grisham MB & Granger ND (1988) Neutrophil-mediated mucosal injury. Role of reactive oxygen species. Digestive Diseases and Sciences 33: 6S-15S.
46. Grisham MB, DeMichele SJ, Garleb KA et al (1996) Sulfasalazine or enteral diets containing fish oil or oligosaccharides attenuate chronic colitis in rats. Inflammatory Bowel Diseases 2: 178-188.
47. Guillemot F, Colombel JF, Neut C et al (1991) Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Diseases of the Colon and Rectum 34: 861-864.
48. Guthy E (1986) Use of alpha-tocopherylquinone in ulcerative colitis. Gut 27: 1400.
49. Gutteridge JMC (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinical Chemistry 41: 1819-1828.
50. Hague A, Manning AM, Hanlon KA et al (1993) Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53 independent pathway: implication for the possible role of dietary fiber in the prevention of large bowel cancer. International Journal of Cancer 55: 498-505.
51. Hallert C, Kaidma M & Petersson BG (1991) Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scandinavian Journal of Gastroenterology 26: 747-750.
52. Hanauer SB, Evans AA, Newcomb SA et al (1984) Can response of ulcerative colitis to total parenteral nutrition (TPN) be predicted? Gastroenterology 86: 1106 (abstract).
53. Harford FJ & Fazio VW (1978) Total parenteral nutrition as primary therapy for inflammatory disease of the bowel. Diseases of the Colon and Rectum 21: 555-557.
54. Hang JM & Soergel KH (1987) Treatment of diversion colitis with short-chain fatty acid irrigation. Gastroenterology 92: 1425(abstract).
55. Hang JM, Soergel KH, Komorowski RA et al (1989) Treatment of diversion colitis with short-chain fatty acid irrigation. New England Journal of Medicine 320: 23-28.
56. Hawthorne AB, Daneshmend TK, Hawkey CJ et al (1992) Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33: 922-928.
57. Hermanowicz A, Sliwinski Z, Kaczor R et al (1985) Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis. Hepatology-Gastroenterology 32: 81-86.
58. Jeejeebhoy KN, Detsky AS & Baker JP (1990) Assessment of nutritional status. Journal of Parenteral and Enteral Nutrition 14: 193S-196S.
59. Kappus H (1985) Lipid peroxidation: mechanisms, analysis, enzymology and biological relevance. In Sies H (ed.) Oxidative Stress, pp 273-310. London: Academic Press.
60. Kehrer JP & Lund LG (1994) Cellular reducing equivalents and oxidative stress. Free Radical Biology and Medicine 17: 65-77.
61. Kim YS, Tsao D, Marita T et al (1982) In Malt RA & Williamson RCN (eds) Colonic Carcinogenesis, pp 317-323. Lancaster: MTP.
62. Klein S, Meyers S, O'Sullivan Pet al (1988) The metabolic impact of active ulcerative colitis: energy expenditure and nitrogen balance. Journal of Clinical Gastroenterology 10: 34-40.
63. Komorowski RA (1990) Histologic spectrum of diversion colitis. American Journal of Surgical Pathology 14: 548-554.
64. Kruh J, Defer N & Tichonicky L (1991) Molecular and cellular effects of sodium butyrate. In Roche AF (ed.) Short-Chain Fatty Acids: Metabolism and Clinical Importance, Report of the Tenth Ross Conference on Medical Research, pp 45-50. Columbus, Ohio: Ross Laboratories.
65. Lashner BA, Heidenreich PA, Su GL et al (1989) Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-controlled study. Gastroenterology 97: 255-259.
66. Lashner BA, Provencher KS, Seidner DL et al (1997) The effect of folic acid supplementation on the risk for cancer of dysplasia in ulcerative colitis. Gastroenterology 112: 29-32.
67. 4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91: 837-844.
68. Lee TH, Hoover RL, Williams JD et al (1985) Effect of dietary enrichment with eicosapentaenoic and docosahexanoic acids of in vitro neutrophil and monocyte leukotriene generation and neutrophil function. New England Journal of Medicine 312: 1217-1224.
69. Leventhal LJ, Boyce EG & Zurier RB (1994) Treatment of rheumatoid arthritis with blackcurrant seed oil. British Journal of Rheumatology 33: 847-852.
70. Lloyd ML & Olsen WA (1995) Disorders of epithelial transport in the small intestine. In Yamada T et al (eds) Textbook of Gastroenterology, 2nd edn, pp 1661-1672. Philadelphia: J.B. Lippincott Co.
71. Lobos EA, Sharon P & Stenson WF (1987) Chemotactic activity in inflammatory bowel disease. Digestive Diseases and Sciences 32: 1380-1388.
72. McCall TB, O'Leary D, Bloomfield J et al (1989) Therapeutic potential of fish oil in the treatment of ulcerative colitis. Alimentary Pharmacology and Therapeutics 3: 415-424.
73. McIntyre PB, Powell-Tuck J, Wood SR et al (1986) Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 27: 481-485.
74. Marotta F, Chui DH, Safran Petal (1995) Shark fin enriched diet prevents mucosal lipid abnormalities in experimental acute colitis. Digestion 56: 46-51.
75. Mattioli S, Miglioli M, Montagna P et al (1988) Wernicke's encephalopathy during total parenteral nutrition: observation in one case. Journal of Parenteral and Enteral Nutrition 12: 626-627.
76. Mulder TPJ, Verspaaget HW, Janssens AR et al (1991) Decreases in two intestinal Cu/Zn containing proteins with antioxidant function in inflammatory bowel disease. Gut 32: 1146-1150.
77. Mulder TPJ, van der Sluys Veer A, Verspaget HW et al (1994) Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 9: 472-477.
78. Mullen JL, Clark Hargrove W, Dudrick SJ et al (1978) Ten years experience with intravenous hyperalimentation and inflammatory bowel disease. Annals of Surgery 187: 523-529.
79. Nelson RA (1968) Intestinal transport, coenzyme-A and colitis in pathothenic acid deficiency. American Journal of Clinical Nutrition 21: 495-501.
80. Nesbitt LT (1995) Minimizing complications from systemic glucocorticosteroid use. Dermatologic Clinics 13: 925-939.
81. Phinney S (1994) Potential risk of prolonged gamma linolenic acid use (letter). Annals of Internal Medicine 120: 692.
82. Poret HA & Kudsk KA (1990) In Rombean JL (ed.) Clinical Nutrition: Parenteral Nutrition, pp 409-426. Philadelphia: W.B. Saunders.
83. Powell-Tuck J (1986) Protein metabolism in inflammatory bowel disease. Gut 27: 67-71.
84. Rao SSC, Holdsworth CD & Forrest ARW (1987) Small intestinal absorption and tolerance of enteral nutrition in acute colitis. British Medical Journal 295: 698.
85. Reid IR & Ibbertson HK (1986) Calcium supplements in the prevention of steroid-induced osteoporosis. American Journal of Clinical Nutrition 44: 287-290.
86. Reilly J, Ryan JA, Strole W et al (1976) Hyperalimentation in inflammatory bowel disease. American Journal of Surgery 131: 192-200.
87. Ringstad J, Kildubo S & Thomassen Y (1993) Serum selenium, copper and zinc concentrations in Crohn's disease and ulcerative colitis. Scandinavian Journal of Gastroenterology 28: 605-608.
88. Roediger WEW (1980a) The colonic epithelium in ulcerative colitis; an energy deficient disease? Lancet ii: 712-715.
89. Roediger WEW (1980b) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21: 793-798.
90. Roediger WEW (1990) The starved colon - diminished mucosal nutrition, diminished absorption and colitis. Diseases of the Colon and Rectum 33: 858-862.
91. Roediger WEW (1991) Cellular metabolism of short-chain fatty acids in colonic epithelial cells. In Roche AF (ed.) Short-Chain Fatty Acids: Metabolism and Clinical Importance, Report of the Tenth Ross Conference on Medical Research, pp 67-71. Columbus, Ohio: Ross Laboratories.
92. Roediger WEW (1992) Oxidative and synthetic functions of n-butyrate in colonocytes (letter). Diseases of the Colon and Rectum 35: 511-512.
93. Roediger WEW & Nance S (1990) Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis. Lipids 25: 646-652.
94. Roediger WEW, Kapaniris O & Millard S (1992) Lipogenesis from n-butyrate in colonocytes: action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis. Molecular and Cellular Biochemistry 118: 113-118.
95. Roediger WEW, Duncan A, Kapaniris O et al (1993a) Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104: 802-809.
96. Roediger WEW, Duncan A, Kapaniris O et al (1993b) Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clinical Science 85: 623-627.
97. Rolandelli RH, Saul SH, Gregg Settle R et al (1988) Comparison of parenteral nutrition and enteral feeding with pectin in experimental colitis in the rat. American Journal of Clinical Nutrition 47: 715-721.
98. Rolandelli RH & Ullrich JR (1997) Lipids and enteral nutrition. In Rombeau JL & Rolandelli RH (eds) Clinical Nutrition: Enteral and Tube Feeding, 3rd edn, pp 47-60. Philadelphia: W.B. Saunders.
99. Rombeau JL & Afonso JJ (1992) Clinical and scientific basis for nutritional support of patients with inflammatory bowel disease. In MacDermott RP & Stenson W (eds) Inflammatory Bowel Disease, pp 525-553. New York: Elsevier.
100. Salim AS (1992) Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach. Journal of Laboratory and Clinical Medicine 119: 710-717.
101. Salomon P, Kornblath AA & Janowitz HD (1990) Treatment of ulcerative colitis with fish oil n-3-ω-fatty acid: an open trial. Journal of Clinical Gastroenterology 12: 157-161.
102. Sandler RS (1993) Epidemiology of inflammatory bowel disease. In Targan SR & Shanahan F (eds) Inflammatory Bowel Disease: from Bench to Bedside, pp 5-30. Baltimore: Williams & Wilkins.
103. Schumert R, Towner J & Zipser RD (1988) Role of eicosanoids in human and experimental colitis. Digestive Diseases and Sciences 33: 58S-64S.
104. Sedghi S, Keshavarzian A, Klamut M et al (1994) Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation. American Journal of Gastroenterology 89: 2217-2221.
105. Seidman EG (1989) Nutritional management of inflammatory bowel disease. Gastroenterology Clinics of North America 17: 129-155.
106. Soergel KH (1991a) The treatment of diversion colitis and pouchitis. In Roche AF (ed.) Short-Chain Fatty Acids: Metabolism and Clinical Importance, Report of the Tenth Ross Conference on Medical Research, pp 82-85. Columbus, Ohio: Ross Laboratories.
107. Soergel KH (1991b) The role of short-chain fatty acids in the treatment of colitis. In Goebell H & Malchow EK (eds) Inflammatory Bowel Diseases. Progress in Basic Research and Clinical Implications, pp 373-379. Dordrecht, Netherlands: Kluwer Academic Press.
108. Stenson WF, Cort D, Rodgers J et al (1992) Dietary supplementation with fish oil in ulcerative colitis. Annals of Internal Medicine 116: 609-614.
109. Stuart Welch C, Adams M & Wakefield EG (1937) Metabolic studies of chronic ulcerative colitis. Journal of Clinical Investigation 16: 161-168.
110. Takada R, Saitoh M & Mori T (1994) Dietary gamma-linolenic acid enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid β-oxidation in rats. Journal of Nutrition 124: 469-474.
111. 5. Prostaglandins 27: 217-232.
112. Valberg LS, Flanagan PR, Kertesz A et al (1986) Zinc absorption in inflammatory bowel disease. Digestive Diseases and Sciences 31: 724-731.
113. Velazquez OC, Jabbar A, DeMatteo RP & Rombeau JL (1996a) Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice. Surgery 120: 440-448.
114. Velazquez OC, Zhou D, Seto RW et al (1996b) In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects of c-fos and c-jun expression. Journal of Parenteral and Enteral Nutrition 20: 243-250.
115. Weiseger RA, Pinkus LM & Jakoby WB (1990) Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide. Biochemical Pharmacology 29: 2885-2887.
116. Wintrobe MM, Follis RH, Alcayaga R et al (1943) Pantothenic acid deficiency in swine, with particular reference to the dietary effects of growth and on the alimentary tract. Bulletin of Johns Hopkins Hospital 73: 313-340.
117. Yamada T & Grisham MB (1993) Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. In Targan SR & Shanahan F (eds) Inflammatory Bowel Disease: from Bench to Bedside, pp 133-150. Baltimore: Williams & Wilkins.
118. Young GP (1991) Butyrate and the molecular biology of the large bowel. In Roche AF (ed.) Short-Chain Fatty Acids: Metabolism and Clinical Importance, Report of the Tenth Ross Conference on Medical Research, pp 39-45. Columbus, Ohio: Ross Laboratories.